Organisation paid for research Program year 2025 Source: CMS Open Payments

Cis Clinical Research Corp

Neither a doctor nor a teaching hospital

Research payments

$104,917

21 payments

Through program year 2025, Cis Clinical Research Corp is reported as receiving $104,917 in research payments, across 21 payments.

By program year

5 rows
Year Kind Amount Payments
2025 Research $95,259 9
2023 Research $950 1
2022 Research $6,131 6
2020 Research $90 2
2019 Research $2,487 3

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novartis Pharmaceuticals Corporation $95,259 9 payments
  2. Medtronic, Inc. $3,931 5 payments
  3. Terumo Medical Corporation $3,150 2 payments
  4. Medtronic Vascular, Inc. $2,577 5 payments
Studies the money was for Research payments · program years 2019–2025
  1. A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardi $46,613 1 payment
  2. Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $24,476 3 payments
  3. A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease $17,000 2 payments
  4. A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) $3,771 1 payment
  5. A Randomized Double-Blind, Placebo-Controlled, Multicenter Trial Assessing the Impact of Lipoprotein (A) Lowering With Tqj230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease $3,399 2 payments
  6. Prospective, Multi-Center, Observational, Post-Market Study to Assess the Safety and Procedural Success of Performing Transradial Access for Treatment of Atherosclerotic Lesions in the Lower Extremities. $3,150 2 payments
  7. Cspot $2,959 2 payments
  8. ECG Belt $2,577 5 payments
  9. EV ICD Pivotal $972 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record